Zoekresultaten - Jonathan C. Trent
- Toon 1 - 20 resultaten van 61
- Ga naar de volgende pagina
-
1
-
2
-
3
Update on the Biology and Therapy of Gastrointestinal Stromal Tumors door Gina Z. D’Amato, Dejka M. Steinert, John C. McAuliffe, Jonathan C. Trent
Gepubliceerd in 2005Revisão -
4
Response of Histiocytoses to Imatinib Mesylate: Fire to Ashes door Filip Janků, Hesham M. Amin, Dan Yang, Ignacio Garrido‐Laguna, Jonathan C. Trent, Razelle Kurzrock
Gepubliceerd in 2010Artigo -
5
Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist door Vivek Subbiah, Robert Brown, Jamie Buryanek, Jonathan C. Trent, Avi Ashkenazi, Roy S. Herbst, Razelle Kurzrock
Gepubliceerd in 2012Artigo -
6
-
7
A two‐arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas door Jonathan C. Trent, Jennifer Beach, M. A. Burgess, Nicholas Papadopolous, Lei L. Chen, Robert S. Benjamin, Shreyaskumar Patel
Gepubliceerd in 2003Artigo -
8
-
9
BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance door Gerald S. Falchook, Jonathan C. Trent, Michael C. Heinrich, Carol Beadling, J. W. Patterson, Christel C. Bastida, S Blackman, Razelle Kurzrock
Gepubliceerd in 2013Artigo -
10
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including <i>VEGFA</i>, in human osteosarcoma door Jilong Yang, Da Yang, Yan Sun, Baocun Sun, Guowen Wang, Jonathan C. Trent, Dejka M. Araujo, Kexin Chen, Wei Zhang
Gepubliceerd in 2011Artigo -
11
-
12
Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment door Jilong Yang, Antti Ylipää, Yan Sun, Hong Zheng, Kexin Chen, Matti Nykter, Jonathan C. Trent, Nancy Ratner, Dina Lev, Wei Zhang
Gepubliceerd in 2011Artigo -
13
Cardiac Tumors in a Tertiary Care Cancer Hospital: Clinical Features, Echocardiographic Findings, Treatment and Outcomes door Syed Wamique Yusuf, Jaya Bathina, S. Qureshi, Husnu E. Kaynak, José Banchs, Jonathan C. Trent, Vinod Ravi, Iyad N. Daher, Joseph Swafford
Gepubliceerd in 2012Artigo -
14
Genetic aberrations of gastrointestinal stromal tumors door Jilong Yang, Xiaoling Du, Alexander J. Lazar, Raphael E. Pollock, Kelly K. Hunt, Kexin Chen, Xishan Hao, Jonathan C. Trent, Wei Zhang
Gepubliceerd in 2008Revisão -
15
Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival door Audrey C. Shor, Elizabeth A. Keschman, Francis Y. Lee, Carlos Muro‐Cacho, G. Douglas Letson, Jonathan C. Trent, W. J. Pledger, Richard Jove
Gepubliceerd in 2007Artigo -
16
Expression of receptor tyrosine kinases epidermal growth factor receptor and HER‐2/<i>neu</i> in synovial sarcoma door Dafydd G. Thomas, Thomas J. Giordano, Donita Sanders, Sybil J. Biermann, Vernon K. Sondak, Jonathan C. Trent, Dihua Yu, Raphael E. Pollock, Laurence Baker
Gepubliceerd in 2005Artigo -
17
Primary angiosarcomas of the breast door Taimur Sher, Bryan T. Hennessy, Vicente Valero, K. Broglio, Wendy A. Woodward, Jonathan C. Trent, Kelly K. Hunt, Gabriel N. Hortobágyi, Ana M. Gonzalez‐Angulo
Gepubliceerd in 2007Artigo -
18
Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor door Renganayaki Pandurengan, Agathe Dumont, Dejka M. Araujo, Joseph A. Ludwig, Vinod Ravi, Shreyaskumar Patel, Judy E. Garber, Robert S. Benjamin, Sanna Ström, Jonathan C. Trent
Gepubliceerd in 2010Artigo -
19
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cell... door Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina Galoian, Andrew E. Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C. Trent
Gepubliceerd in 2015Artigo -
20
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor door Chandrajit P. Raut, N. Joseph Espat, Robert G. Maki, Dejka M. Araujo, Jonathan C. Trent, Toni Faith Williams, Das Purkayastha, Ronald P. DeMatteo
Gepubliceerd in 2018Artigo
Zoekinstrumenten:
Gerelateerde Onderwerpen
Medicine
Internal medicine
Oncology
Biology
Cancer
Cancer research
Stromal cell
Gene
GiST
Pathology
Genetics
Surgery
Myeloid leukemia
Imatinib
Chemotherapy
Imatinib mesylate
Stromal tumor
Gastroenterology
PDGFRA
Sarcoma
Mutation
Adverse effect
Colorectal cancer
Confidence interval
Disease
Progressive disease
Biochemistry
Breast cancer
Gene expression
Metastasis